期刊文献+

肺表面活性蛋白-D功能及其在肺部常见疾病中的研究进展

Research progress on the function of surfactant protein-D and its role in the common lung diseases
原文传递
导出
摘要 肺表面活性蛋白-D(SP-D)是凝集素家族糖蛋白,主要在肺部的肺泡Ⅱ型上皮细胞和无纤毛细支气管上皮细胞合成和分泌,储存在Clara细胞的分泌颗粒中。SP-D是表面结合蛋白之一,也是组成肺表面活性系统的一部分。SP-D除了有助于肺泡空间内表面活性剂池稳态外,还具有宿主防御和免疫调节功能。本文通过对近年来SP-D在肺部常见疾病中的部分相关研究进行总结,为众多肺部疾病,特别是肺部炎症性疾病潜在的治疗提供重要的方法理论基础。 Lung surfactant protein D(SP-D)is a glycoprotein of the lectin family.In lungs it is synthesized and secreted mainly in the alveolar typeⅡepithelial cells and non-ciliated bronchiole epithelial cells,and are stored in secretory granules of Clara cells.SP-D is one of the surfactant binding proteins and is also a part of the pulmonary surfactant system.In addition to contributing to the homeostasis of surfactant pools in alveolar space,SP-D also exhibits functions of host defense and immunoregulation.This paper summarizes some relevant studies on SP-D in acute lung diseases in recent years,providing important theoretical basis for the potential treatment of many lung diseases,especially in inflammatory lung diseases.
作者 刘娟丽 马四清 陈强 Liu Juanli;Ma Siqing;Chen Qiang(Department of Critical Care Medicine,Qinghai Provincial People′s Hospital,Xining 810007,China;Plateau Medical Center of Qinghai University,Xining 810001,China)
出处 《中华重症医学电子杂志》 CSCD 2022年第2期167-172,共6页 Chinese Journal Of Critical Care & Intensive Care Medicine(Electronic Edition)
基金 国家自然科学基金项目(81860351) 青海省高原重症医学重点实验室项目(2020-81) 青海省高原医学应用基础重点实验室(青海-犹他高原医学联合重点实验室)项目(2022-ZJ-Y15)。
关键词 表面活性蛋白-D 表面活性剂池稳态 宿主防御 免疫调节 Surfactant proteins D Homeostasis of surfactant pools Host defense Immune regulation
  • 相关文献

参考文献3

二级参考文献48

  • 1张钢,高钰琪,张璐.缺氧对大鼠血液流变学特性的影响[J].重庆医学,2006,35(17):1574-1576. 被引量:15
  • 2Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and out-comes of sepsis - related vs non - sepsis - related ARDS [ J]. Chest,2010,138(3):559 -567.
  • 3Fukuda Y. Acute lung injury/acute respiratory distress syndrome: pro-gress in diagnosis and treatment. Topics: I. Pathogenesis and patho-physiology :4. Pathophysiology and histopathology of AT,T/ARDS[ J].Nihon Naika Gakkai zasshi, 2011,100(6) : 1536 - 1540.
  • 4Janz DR, Ware LB. Biomarkere of ALI/AKDS: Pathogenesis, Discov-ery ,and Relevance to Clinical Trials. Seminars in respiratory and criticalcare medicine[ J]. Semin Respir Crit Care Med, 2013,34(4) :537 -548.
  • 5Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septicshock: 2012[J]. Crit Care Med, 2013,41(2) :580 -637.
  • 6ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, ThompsonBT,et al. Acute respiratory distress syndrome : the Berlin Definition[J]. JAMA, 2012,307(23):2526 -2533.
  • 7Willems CH,Zimmermann LJ,Langen RM,et al. Surfactant protein Ainfluences reepithelialization in an alveolocapillary model system [ J],Lung,2012,190(6) :661 -669.
  • 8Liamina SV, Shimshelashvili ShL, Malyshev IIu. Surfactant protein Dendogenous regulator of inflammation and immune defense [ J]. Patol Fi-ziol Eksp Ter, 2012,(1) :60 -66..
  • 9Shrive AK, Martin C, Bums I,et al. Structural characterisation of lig-and -binding determinants in human lung surfactant protein D: influenceof AsP325[J]. J Mol Biol, 2009,394(4) :776 -788.
  • 10Boonarkart CH, Suptawiwat 0,Uiprasertkul M. A reduced expressionof surfactant protein D in the lungs of fatal influenza H1N1 cases in 2009[J]. Acta Virol, 2012,56(3) :253 -255.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部